Mini Review
Published on 27 Nov 2023
HyBryte™ use in early-stage cutaneous T-cell lymphoma
in Dermatologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298453
- 1,317 views
Type at least 3 characters
113 articles
Articles
Editorial
Published on 23 Nov 2023
Editorial: Advances in anti-malarial drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1335842
- 624 views
Original Research
Published on 22 Nov 2023
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298916
- 1,709 views
Review
Published on 21 Nov 2023
Future treatments for the arteriopathy of ectopic calcification disorders
in Cardiovascular and Hematologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249966
- 1,007 views
Original Research
Published on 14 Nov 2023
In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1257698
- 750 views
Original Research
Published on 30 Oct 2023
An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1289314
- 1,211 views
Review
Published on 18 Sep 2023
State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1254656
- 1,296 views
Mini Review
Published on 05 Sep 2023
Harnessing bioluminescence for drug discovery and epigenetic research
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249507
- 1,596 views
- 1 citation
Brief Research Report
Published on 03 Aug 2023
Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1216516
- 2,140 views
- 2 citations
Review
Published on 25 Jul 2023
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1237655
- 1,331 views
- 2 citations
Original Research
Published on 20 Jul 2023
9-PAHSA displays a weak anti-inflammatory potential mediated by specific antagonism of chemokine G protein-coupled receptors
in Anti-inflammatory and Immunomodulating Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1138461
- 1,217 views
Review
Published on 13 Jul 2023
Targeting proteases and proteolytic processing of unusual N-terminal extensions of Plasmodium proteins: parasite peculiarity
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1223140
- 1,181 views
Mini Review
Published on 12 Jul 2023
FAIR data management: what does it mean for drug discovery?
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1226727
- 1,565 views
Original Research
Published on 07 Jul 2023
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1181637
- 766 views
Review
Published on 21 Jun 2023
Yin-yang in drug discovery: rethinking de novo design and development of predictive models
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1222655
- 3,384 views
- 3 citations
Original Research
Published on 15 Jun 2023
MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1190471
- 1,158 views